Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis

IF 3.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Daniel J. Slack MD , Nithya Krishnamurthy BA , Derek Chen MS , Felix G. Contreras-Castro BA , Joshua D. Safer MD
{"title":"Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis","authors":"Daniel J. Slack MD ,&nbsp;Nithya Krishnamurthy BA ,&nbsp;Derek Chen MS ,&nbsp;Felix G. Contreras-Castro BA ,&nbsp;Joshua D. Safer MD","doi":"10.1016/j.eprac.2024.08.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The risk of venous thromboembolism (VTE) with feminizing gender-affirming hormone therapy is an area of concern. This analysis aimed to assess whether gender-affirming hormone therapy and other potential risk factors are associated with VTE in transfeminine and gender diverse individuals.</div></div><div><h3>Methods</h3><div>We conducted a chart review of 2126 transfeminine and gender diverse adults receiving care within a large urban health system. The primary outcomes were the prevalence of VTE and odds ratios for the association of VTE with insurer, use of estrogen, and select comorbidities.</div></div><div><h3>Results</h3><div>A history of VTE was documented in 0.8% of the cohort. Those with a history of VTE were older (<em>P</em> &lt; .001), more often self-identified as Hispanic or Black compared to White or Asian (<em>P</em> &lt; .05) and were more likely to have Medicaid or Medicare (<em>P</em> &lt; .01) when compared to those without a history of VTE. The prevalence of hyperlipidemia (<em>P</em> &lt; .001), diabetes mellitus (<em>P</em> &lt; .05), and hypercoagulable conditions (<em>P</em> &lt; .001) were all greater in the positive VTE group. Hyperlipidemia (<em>P</em> &lt; .001), diabetes mellitus (<em>P</em> &lt; .05), and insurer (<em>P</em> &lt; .05) were associated with increased odds of VTE in univariate analyses. None of the exposure variables analyzed were associated with VTE when controlling for age, race, and the number of comorbidities.</div></div><div><h3>Conclusions</h3><div>The prevalence of VTE in our cohort was lower than previously observed. VTE was not associated with any one risk factor, including estrogen use, when controlling for age, race, and the number of comorbidities. Those of advanced age and those with multiple cardiometabolic comorbidities may benefit from increased surveillance and mitigation of modifiable risk factors.</div></div>","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":"30 11","pages":"Pages 1066-1072"},"PeriodicalIF":3.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1530891X24006633","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The risk of venous thromboembolism (VTE) with feminizing gender-affirming hormone therapy is an area of concern. This analysis aimed to assess whether gender-affirming hormone therapy and other potential risk factors are associated with VTE in transfeminine and gender diverse individuals.

Methods

We conducted a chart review of 2126 transfeminine and gender diverse adults receiving care within a large urban health system. The primary outcomes were the prevalence of VTE and odds ratios for the association of VTE with insurer, use of estrogen, and select comorbidities.

Results

A history of VTE was documented in 0.8% of the cohort. Those with a history of VTE were older (P < .001), more often self-identified as Hispanic or Black compared to White or Asian (P < .05) and were more likely to have Medicaid or Medicare (P < .01) when compared to those without a history of VTE. The prevalence of hyperlipidemia (P < .001), diabetes mellitus (P < .05), and hypercoagulable conditions (P < .001) were all greater in the positive VTE group. Hyperlipidemia (P < .001), diabetes mellitus (P < .05), and insurer (P < .05) were associated with increased odds of VTE in univariate analyses. None of the exposure variables analyzed were associated with VTE when controlling for age, race, and the number of comorbidities.

Conclusions

The prevalence of VTE in our cohort was lower than previously observed. VTE was not associated with any one risk factor, including estrogen use, when controlling for age, race, and the number of comorbidities. Those of advanced age and those with multiple cardiometabolic comorbidities may benefit from increased surveillance and mitigation of modifiable risk factors.
评估变性人和不同性别人群的静脉血栓栓塞风险:回顾性分析。
目的:女性化性别确认激素疗法(GAHT)的静脉血栓栓塞症(VTE)风险是一个值得关注的领域。本分析旨在评估GAHT和其他潜在风险因素是否与变性和性别多元化(TGD)人群的VTE相关:我们对一个大型城市医疗系统中接受治疗的 2,126 名 TGD 成人进行了病历审查。主要结果是 VTE 的患病率以及 VTE 与保险人、雌激素的使用和特定合并症相关的几率比:结果:0.8%的患者有 VTE 病史。有 VTE 病史的患者年龄较大(p 结论:该群体中 VTE 患病率为 0.8%:我们队列中的 VTE 患病率低于之前的观察结果。在控制年龄、种族和合并症数量的情况下,VTE 与包括使用雌激素在内的任何一个风险因素都无关。那些高龄和患有多种心脏代谢合并症的人可能会从加强监测和减少可改变的风险因素中获益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine Practice
Endocrine Practice ENDOCRINOLOGY & METABOLISM-
CiteScore
7.60
自引率
2.40%
发文量
546
审稿时长
41 days
期刊介绍: Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信